<DOC>
	<DOCNO>NCT01009567</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety cabergoline prevention ovarian hyperstimulation syndrome versus albumin ART program .</brief_summary>
	<brief_title>Compare Efficacy Human Albumin With Cabergoline Prevent Ovarian Hyper Stimulation Assisted Reproductive Technology ( ART ) Program</brief_title>
	<detailed_description>Ovarian hyperstimulation syndrome ( OHSS ) iatrogenic potentially life threaten complication assist reproduction technology due gonadotropin human chorionic gonadotropin administration . Its severe form report 1-10 % vitro fertilization cycle . Different strategy propose prevention OHSS high-risk patient , approach offer complete protection development ovarian hyperstimulation syndrome ( OHSS ) . Among select preventive method , discontinue ( coast ) gonadotropin therapy i.v . albumin far popular choice . Several previous study show cabergoline safe drug , mother conceptus , treatment macroadenoma hyperprolactinemia . We think kind therapy may safe mother conceptus ( previously show several study dopamine agonist treatment hyperprolactinemia pregnancy ) , easy , cheap probably , effective previous OHSS treatment ( albumin , steroid , dopamine ) . There urgent need test cabergoline efficacy OHSS prevention high risk patient large multicenter study . The proposal This study approve institutional review board institution 's ethical committee , Participants sign write consent enter study . Patients enter intracytoplasmic sperm injection ( ICSI ) / IVF program Royan institute infertility research center Valieasr hospital Iran . We use downregulation protocol GnRH agonist ( buserelin acetate ) long protocol ICSI/ IVF-ET . We evaluate patient high risk factor severe OHSS . The inclusion criterion collection &gt; 20 oocyte oocyte retrieval . They allocate series computer-generated random two group oocytes retrieval . 30 minute oocyte retrieval patient A Group , receive human albumin 20 % infusion B group receive cabergoline tablet ( 0/5 mg ) daily 6 day oocytes retrieval woman group inform sign symptom OHSS counsel contact institute OHSS develop . Patients monitor routinely 6days ET ultrasonographic examination ovarian size detection ascites . Moderate severe OHSS patient hospitalize evaluate routinely haematological biochemical test . OHSS patient diagnose classify accord Golan et al 1989.we compare incidence OHSS severity OHSS patient two group . Pregnant patient follow 12th gestational week .</detailed_description>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Cabergoline</mesh_term>
	<criteria>patient risk develop OHSS , define development 2030 follicle large 12 mm diameter retrieval 20 oocyte ovarian stimulation long protocol coast case</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>OHSS</keyword>
</DOC>